Cosmegen

In some countries, this medicine may only be approved for veterinary use.

In the US, Cosmegen (dactinomycin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Cancer, Ewing's Sarcoma, Osteoarthritis, Osteosarcoma, Ovarian Cancer, Rhabdomyosarcoma, Testicular Cancer, Trophoblastic Disease and Wilms' Tumor.

US matches:

• Cosmegen

Ingredient matches for Cosmegen

Dactinomycin

Dactinomycin is reported as an ingredient of Cosmegen in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Brazil


• Bulgaria


• Egypt


• Estonia


• Hong Kong


• Iran


• Iraq


• Japan


• Jordan


• Kuwait


• Lebanon


• New Zealand


• Norway


• Oman


• Philippines


• Qatar


• Saudi Arabia


• Switzerland


• Syria


• Taiwan


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Yemen

International Drug Name Search